Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism

scientific article

Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism is …
instance of (P31):
scholarly articleQ13442814
retracted paperQ45182324

External links are
P356DOI10.1172/JCI23187
P932PMC publication ID548317
P698PubMed publication ID15711641

P50authorCullen M. TaniguchiQ58667910
Kohjiro UekiQ65013004
P2093author name stringRonald Kahn
P2860cites workDisruption of IRS-2 causes type 2 diabetes in miceQ24316112
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transductionQ24338592
CRE recombinase-inducible RNA interference mediated by lentiviral vectorsQ24562287
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouseQ24564225
Cre-lox-regulated conditional RNA interference from transgenesQ24564248
RNA interferenceQ28131798
Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob miceQ28144106
Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinaseQ28508079
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanismsQ28586863
Rational siRNA design for RNA interferenceQ29614450
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interferenceQ29615920
A DNA vector-based RNAi technology to suppress gene expression in mammalian cellsQ29616551
Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathwaysQ29618467
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interactionQ29619822
Control of siRNA expression using the Cre-loxP recombination system.Q33833394
Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.Q52541535
Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats.Q54150649
Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic DysfunctionQ61203351
Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null allelesQ73085036
Insulin receptor substrate (IRS)-2 is dephosphorylated more rapidly than IRS-1 via its association with phosphatidylinositol 3-kinase in skeletal muscle cellsQ73316496
Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker ratsQ74034144
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunctionQ74191142
ADD1/SREBP-1c mediates insulin-induced gene expression linked to the MAP kinase pathwayQ77126146
Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activityQ33834971
Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitusQ34061740
Free fatty acids and pathogenesis of type 2 diabetes mellitusQ34066567
Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesisQ34920348
Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistanceQ35608446
Site and mechanism of leptin action in a rodent form of congenital lipodystrophyQ35631912
Generation of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter.Q35965403
Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetesQ36698641
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscleQ37175187
Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouseQ37376749
Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.Q37388544
Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liverQ38297185
Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liverQ39740783
Insulin signaling is required for insulin's direct and indirect action on hepatic glucose productionQ39741170
Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient miceQ40019067
Restored insulin-sensitivity in IRS-1-deficient mice treated by adenovirus-mediated gene therapyQ40437444
Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathwayQ40620552
Regulation of leptin secretion from white adipocytes by free fatty acidsQ42440847
Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetesQ42460893
The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action.Q42804257
Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.Q42805819
Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2.Q42829442
Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesisQ42831589
Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic miceQ43966288
Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytesQ44007180
Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats.Q44286316
Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytesQ44564021
Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the DogQ44599780
Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetesQ44675026
Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) miceQ44804017
Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1.Q44814519
PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.Q44859720
SREBPs suppress IRS-2-mediated insulin signalling in the liverQ47868873
Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo.Q48702756
Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling.Q52174749
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.Q52507538
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)718-727
P577publication date2005-03-01
P1433published inJournal of Clinical InvestigationQ3186904
P1476titleComplementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
P478volume115